OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
09037058

MetaLabs Co Ltd

Business Support ServicesVerified

MetaLabs Co Ltd exhibits a capital structure with a debt-to-equity ratio of 1.25, indicating a moderate reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.51 and negative free cash flow of -10,462,554,120 KRW. The negative operating cash flow of -2,496,725,730 KRW further signals cash flow constraints. Profitability metrics are negative, with a return on equity of -12.57% and a return on assets of -3.52%. These figures fall significantly below the industry median for profitability, suggesting underperformance relative to peers. The company's operating income is negative at -10,618,853,130 KRW, and net income is also negative at -8,789,647,440 KRW, indicating a lack of operational profitability. The company's revenue is concentrated across three segments: Medical Service Consulting, Fashion Manufacturing and Sales, and Cosmetics Manufacturing, Sales and Other. The Fashion segment is the primary revenue driver, but the company's exposure to the apparel industry makes it vulnerable to shifts in consumer demand and fashion trends. The geographic exposure is not disclosed, but the company is based in South Korea, which may limit its diversification. Growth prospects are constrained, with no clear indication of revenue expansion in the current or next fiscal year. The company's operating income and net income have deteriorated, and the negative free cash flow suggests limited capacity for reinvestment or debt servicing. The absence of positive growth signals in the financial data raises concerns about the company's ability to sustain operations. The risk assessment highlights medium liquidity risk and low dilution risk. The company's negative net cash position after subtracting total debt is a key flag. The dilution risk is low, but the company's financial instability could lead to future capital-raising activities that may dilute existing shareholders. Recent financial filings and transcripts indicate a challenging operating environment. The company's last actual EPS was -1,535.00 KRW, and its last actual revenue was 47,357,000,000 KRW, both of which reflect a decline in performance. The absence of positive developments in recent disclosures suggests ongoing operational and financial difficulties.

30-day price · 090370-157.00 (-11.1%)
Low$1255.00High$1569.00Close$1256.00As of22 May, 00:00 UTC
Profile
CompanyMetaLabs Co Ltd
Ticker090370.KS
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryBusiness Support Services
AI analysis

Business. MetaLabs Co Ltd operates in the casual clothing business through its Fashion Manufacturing and Sales segment, while also providing medical consulting services and engaging in cosmetics manufacturing and sales.

Classification. MetaLabs is classified under the Industrials economic sector, Industrial & Commercial Services business sector, and Business Support Services industry with a confidence level of 0.92.

MetaLabs Co Ltd exhibits a capital structure with a debt-to-equity ratio of 1.25, indicating a moderate reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.51 and negative free cash flow of -10,462,554,120 KRW. The negative operating cash flow of -2,496,725,730 KRW further signals cash flow constraints. Profitability metrics are negative, with a return on equity of -12.57% and a return on assets of -3.52%. These figures fall significantly below the industry median for profitability, suggesting underperformance relative to peers. The company's operating income is negative at -10,618,853,130 KRW, and net income is also negative at -8,789,647,440 KRW, indicating a lack of operational profitability. The company's revenue is concentrated across three segments: Medical Service Consulting, Fashion Manufacturing and Sales, and Cosmetics Manufacturing, Sales and Other. The Fashion segment is the primary revenue driver, but the company's exposure to the apparel industry makes it vulnerable to shifts in consumer demand and fashion trends. The geographic exposure is not disclosed, but the company is based in South Korea, which may limit its diversification. Growth prospects are constrained, with no clear indication of revenue expansion in the current or next fiscal year. The company's operating income and net income have deteriorated, and the negative free cash flow suggests limited capacity for reinvestment or debt servicing. The absence of positive growth signals in the financial data raises concerns about the company's ability to sustain operations. The risk assessment highlights medium liquidity risk and low dilution risk. The company's negative net cash position after subtracting total debt is a key flag. The dilution risk is low, but the company's financial instability could lead to future capital-raising activities that may dilute existing shareholders. Recent financial filings and transcripts indicate a challenging operating environment. The company's last actual EPS was -1,535.00 KRW, and its last actual revenue was 47,357,000,000 KRW, both of which reflect a decline in performance. The absence of positive developments in recent disclosures suggests ongoing operational and financial difficulties.
Key takeaways
  • MetaLabs Co Ltd is operating at a loss with negative operating and net income.
  • The company's liquidity position is weak, with a current ratio of 0.51 and negative free cash flow.
  • Profitability metrics are significantly below industry medians, indicating underperformance.
  • The company's revenue is concentrated across three segments, with the Fashion segment being the primary driver.
  • Growth prospects are limited, with no clear signs of improvement in the current or next fiscal year.
  • The risk assessment highlights medium liquidity risk and low dilution risk.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$81.32B
Gross profit$9.89B
Operating income-$10.62B
Net income-$8.79B
R&D
SG&A
D&A
SBC
Operating cash flow-$2.50B
CapEx-$1.52B
Free cash flow-$10.46B
Total assets$249.95B
Total liabilities$180.02B
Total equity$69.93B
Cash & equivalents$4.06B
Long-term debt$87.33B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$69.93B
Net cash-$83.27B
Current ratio0.5
Debt/Equity1.2
ROA-3.5%
ROE-12.6%
Cash conversion28.0%
CapEx/Revenue-1.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Services · cohort 6 companies
Metric090370Activity
Op margin-13.1%11.2% medp25 7.1% · p75 18.5%bottom quartile
Net margin-10.8%13.8% medp25 13.8% · p75 13.8%bottom quartile
Gross margin12.2%94.7% medp25 62.9% · p75 126.4%bottom quartile
R&D / revenue6.0% medp25 6.0% · p75 6.0%
CapEx / revenue-1.9%6.7% medp25 4.4% · p75 7.4%bottom quartile
Debt / equity125.0%136.7% medp25 101.5% · p75 217.7%below median
Observations
IR observations
Last actual EPS-1,535.00 KRW
Last actual revenue47,357,000,000 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 12:42 UTC#866addac
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 19:39 UTCJob: defe8f26